Mineralization of Trichloroethylene by Heterotrophic Enrichment Cultures

Microbial consortia capable of aerobically degrading more than 99% of exogenous trichloroethylene (TCE) (50 mg/liter) were collected from TCE-contaminated subsurface sediments and grown in enrichment cultures. TCE at concentrations greater than 300 mg/liter was not degraded, nor was TCE used by the consortia as a sole energy source. Energy sources which permitted growth included tryptone-yeast extract, methanol, methane, and propane. The optimum temperature range for growth and subsequent TCE consumption was 22 to 37°C, and the pH optimum was 7.0 to 8.1. Utilization of TCE occurred only after apparent microbial growth had ceased. The major end products recovered were hydrochloric acid and carbon dioxide. Minor products included dichloroethylene, vinylidine chloride, and, possibly, chloroform.     

Microfluidic-based 18F-labeling of biomolecules for immuno-positron emission tomography

Methods for tagging biomolecules with fluorine 18 as immuno-positron emission tomography (immunoPET) tracers require tedious optimization of radiolabeling conditions and can consume large amounts of scarce biomolecules. We describe an improved method using a digital microfluidic droplet generation (DMDG) chip, which provides computer-controlled metering and mixing of 18F tag, biomolecule, and buffer in defined ratios, allowing rapid scouting of reaction conditions in nanoliter volumes. The identified optimized conditions were then translated to bench-scale 18F labeling of a cancer-specific engineered antibody fragments, enabling microPET imaging of tumors in xenografted mice at 0.5 to 4 hours postinjection.     

Bovine aortic chondroitin sulphate- and dermatan sulphate-containing proteoglycans. Isolation, fractionation and chemical characterization.

1. Guanidinium chloride (4M) in the presence of proteinase inhibitors extracted 90% of bovine aorta galactosaminoglycans as proteoglycans that were subsequently purified by ion-exchange and gel chromatography. 2. Fractionation of the calcium salts of the purified proteoglycans with increasing concentration of ethanol yielded fractions PG-25 (28%), PG-35 (45%) and PG-50 (37%). 3. Fraction PG-50 contained proteochondroitin 6-sulphate, whereas fractions PG-25 and PG-35 were proteodermatan sulphates of greatly different carbohydrate composition; the molar proportions of L-iduronate-N-acetylgalactosamine 4-sulphate, D-glucuronate-N-acetyl-galactosamine 4-sulphate and D-glucuronate-N-acetylgalactosamine 6-sulphate were 75: 18 :7 in fraction PG-25 and 14 :46 :40 in fraction PG-35. 4. The presence of alternating or mixed sequences with L-iduronate- and D-glucuronate-containing repeating disaccharides was indicated by the formation of tetrasaccharides after chondroitinase AC digestion (single L-iduronate residues) and by the release of fragments containing four or five consecutive D-glucuronate-N-acetylgalactosamine repeats after periodate oxidation and alkaline elimination. 5. The amino acid compositions of fractions PG-25 and PG-35 were similar and markedly different from that of fraction PG-50, which also contained more side chains.     

A novel method for measuring medial compartment pressures within the knee joint in-vivo

A novel method for the measurement of knee joint forces in-vivo is described. A thin (0.2mm) flexible electronic pressure sensor was inserted through a narrow arthroscopic portal into the osteoarthritic medial compartment of the knee joint. The sensor partially covered the load bearing area. The surgery was performed under local anaesthetic during normal arthroscopic examination following patient consent. Results are presented for 11 patients. The method was used in a pilot study to assess the effects of four valgus knee braces on medial compartment forces. An analysis of variance could not detect un-loading by any brace although there were large variations in force output. These variations may be attributable to shifts in the sensor position. In-vivo measurement of joint force is technically feasible.     

Visualization of cellular aggregates cultured on a three dimensional collagen sponge matrix

Summary A one-step vital stain is described for the macroscopic visualization of histotypic cell aggregates in fetal rat lung organotypic cultures. Organotypic cultures are incubated in 0.05-0.1% 2,3,5′-triphenyl tetrazolium chloride (TTC) in culture medium (37°C). Living cells reduce the tetrazole to a water-insoluble red colored formazan. Cell aggregates appear as densely stained foci against the lighter background of the Gelfoam substrate. Stained cultures may be scanned macroscopically to determine the degree of reaggregation and assess cell viability. Identification of aggregates by TTC staining improves the efficiency of tissue processing for electron microscopy and does not alter the ultrastructural appearance of the cultured cells. This work was funded in part by the United Cerebral Palsy Research and Educational Foundation, Inc. and the National Heart, Lung, and Blood Institute (Grants 1ROHL19513 and 1 R01HL21008).     

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

Fabry disease results from deficient alpha-galactosidase A (alpha-Gal A) activity and the pathologic accumulation of the globotriaosylceramide (GL-3) and related glycosphingolipids, primarily in vascular endothelial lysosomes. Treatment is currently palliative, and affected patients generally die in their 40s or 50s. Preclinical studies of recombinant human alpha-Gal A (r-halphaGalA) infusions in knockout mice demonstrated reduction of GL-3 in tissues and plasma, providing rationale for a phase 1/2 clinical trial. Here, we report a single-center, open-label, dose-ranging study of r-halphaGalA treatment in 15 patients, each of whom received five infusions at one of five dose regimens. Intravenously administered r-halphaGalA was cleared from the circulation in a dose-dependent manner, via both saturable and non-saturable pathways. Rapid and marked reductions in plasma and tissue GL-3 were observed biochemically, histologically, and/or ultrastructurally. Clearance of plasma GL-3 was dose-dependent. In patients with pre- and posttreatment biopsies, mean GL-3 content decreased 84% in liver (n=13), was markedly reduced in kidney in four of five patients, and after five doses was modestly lowered in the endomyocardium of four of seven patients. GL-3 deposits were cleared to near normal or were markedly reduced in the vascular endothelium of liver, skin, heart, and kidney, on the basis of light- and electron-microscopic evaluation. In addition, patients reported less pain, increased ability to sweat, and improved quality-of-life measures. Infusions were well tolerated; four patients experienced mild-to-moderate reactions, suggestive of hypersensitivity, that were managed conservatively. Of 15 patients, 8 (53%) developed IgG antibodies to r-halphaGalA; however, the antibodies were not neutralizing, as indicated by unchanged pharmacokinetic values for infusions 1 and 5. This study provides the basis for a phase 3 trial of enzyme-replacement therapy for Fabry disease.     

A laboratory examination of substrate, water depth, and light use at two water velocity levels by individual juvenile pallid (Scaphirhynchus albus) and shovelnose (Scaphirhynchus platorynchus) sturgeon

We investigated the influence of substrate type, water depth, light, and relative water velocity on microhabitat selection in juvenile pallid (Scaphirhynchus albus) and shovelnose (Scaphirhynchus platorynchus) sturgeon. Individual sturgeon were placed in an 18 927 L elliptical flume, and their location was recorded after a 2‐h period. Data were analyzed using exact chi‐square goodness of fit tests and exact tests of independence. Both sturgeon species used substrate, depth, and light in similar proportions. (all comparisons; P > 0.05). Specifically, pallid and shovelnose sturgeon did not use substrate in proportion to its availability (pallid: P = 0.0026; shovelnose: P = 0.0199). Each species used sand substrate more and gravel substrate less than expected based on availability. Additionally, neither species used woody structure. Both species used deep areas in greater proportion than availability while shallow areas were used less than expected based on availability (pallid; P < 0.0001; shovelnose; P = 0.0335). Pallid and shovelnose sturgeon used very dark areas in greater proportion than expected based on availability; however, very light areas were used in lower proportion than expected (P < 0.0001). Overall, neither species changed their use of habitat in relation to a change in water velocity (pallid, all comparisons P > 0.05; shovelnose, all comparisons P > 0.05). This study is the first investigation of juvenile pallid and shovelnose sturgeon habitat selection in a large‐scale artificial stream system. Field studies of microhabitat selection by juvenile pallid and shovelnose sturgeon should be carried out to substantiate the results of this study, and to identify critical habitat for recovery and management of sturgeon species. Due to the extensive range, longevity, and migratory behavior of these fishes, proper management likely requires river improvements that provide sturgeon with access to a broad range of habitat conditions over time, including system‐wide habitat diversity; natural variation in flow, velocity, temperature, and turbidity; high water quality; a broad prey base; free‐flowing river sections which provide suitable spawning and rearing sites, as well as protection from recreational and commercial harvesting.     

Use of diethylstilbestrol and ethynylestradiol to feminize Nile tilapia Oreochromis niloticus (L.) in an outdoor environment

Two synthetic estrogens, diethylstilbestrol (DES) and ethynylestradiol (EE), were orally administered to 8.7 mm gonadally undifferentiated Oreochromis niloticus fry for a period of 28 days in an outdoor setting. Diethylstilbestrol was administered at doses of 100 mg, 200 mg, and 400 mg per kg diet. Ethynylestradiol was administered at 50 mg, 100 mg, and 200 mg per kg diet. One group received a non-hormone-treated feed. Hormone treatments produced significantly more (P < 0.05) than 50% females indicating that genotypic male fish were sex-reversed to phenotypic females. No rate of estrogen administration resulted in a 100% female population. Ethynylestradiol (EE) treatments resulted in 58–65% females, 32–35% males, and 3–9% hermaphrodites. Diethylstilbestrol (DES) treatments resulted in 60–80% females, 13–37% males, and 1–7% hermaphrodites. The DES 400 treatment was the most effective in altering phenotypic sex: 80% females, 13% males, 7% hermaphrodites.     

Inhibition of purified mitochondiral ATPase (F1) by bathophenanthroline and relief of the inhibition by uncouplers.

Low concentrations of bathophenanthroline inhibit the ATPase activity of purified beef-heart F₁. The inhibition is antagonized by ATP in a fashion consistent with the involvement of a regulatory site on the enzyme. Various uncouplers, including FCCP, S-13, TTFB, dicoumarol and 2,4-dinitrophenol, relieve the bathophenanthroline inhibition, in concentrations similar to those known to uncouple mitochondrial oxidative phosphorylation.     

N-ethylmaleimide inhibits Ncd motor function by modification of a cysteine in the stalk domain.

N-Ethylmaleimide (NEM), which reacts readily with exposed sulfhydryl groups, has been shown to inhibit the activity of the microtubule (MT) motors kinesin, Ncd, and dynein. Currently, the mechanism of inhibition is not known for any of these proteins. To investigate the mechanism by which NEM inhibits Ncd, the recombinant Ncd motor-stalk protein MC1 (modified claret 1) was treated with varying concentrations of NEM (0-10 mM) and cosedimentation and ATPase assays were used to assess the effects of modification on MC1 interactions with MTs. In the cosedimentation assay, treatment with /=0.5 mM NEM induced aggregation of MC1 and resulted in sedimentation of the motor in the absence of MTs. NEM modification had no effect on the basal ATPase rate but produced a decrease in the MT-stimulated ATPase rate. Labeling of MC1 with [3H]NEM indicated that enhanced MT binding was associated with an average labeling of 1 Cys residue per MC1 polypeptide, while aggregation was associated with an average labeling of 2 Cys residues per MC1 polypeptide. Protein digestion, structural analysis, and mass spectrometry indicate that modification of Cys313 or Cys324 in the stalk domain is correlated with enhanced binding of MC1 to MTs. These results suggest that NEM enhances Ncd binding to MTs by disruption of neck and/or stalk function and demonstrate the importance of this region in motor function.